Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marian Wiegand"'
Autor:
Christine Kaufmann, Lemmermann Naw, Richard Kiener, Ralf Wagner, Marian Wiegand, Schwegler C, Angélique Renzaho, Benedikt Asbach, Felder E, Fleischmann M, Hans-Helmut Niller, Simone Thomas
Publikováno v:
Journal of virology. 92(15)
Human cytomegalovirus (HCMV) represents a major cause of clinical complications during pregnancy as well as immunosuppression, and the licensing of a protective HCMV vaccine remains an unmet global need. Here, we designed and validated novel Sendai v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6908cb42b06a1a50466a1c0162f07ee
https://pubmed.ncbi.nlm.nih.gov/29769344
https://pubmed.ncbi.nlm.nih.gov/29769344
Autor:
Gianni Gori-Savellini, Maria Giulia Disanto, Marian Wiegand, Christine Kaufmann, Guido Papa, Claudia Gandolfo, Alessandro Ginori, Maria Grazia Cusi, Donatella Spina, Eva Felder
Respiratory syncytial virus (RSV) is a major cause of severe respiratory infections in children and elderly people, and no marketed vaccine exists. In this study, we generated and analyzed a subunit vaccine against RSV based on a novel genome replica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88e0ea73ab8766fef9580799993c903e
http://hdl.handle.net/11365/1004817
http://hdl.handle.net/11365/1004817
Autor:
Orhan Ilter, René R. Marty, Mathias Liniger, Sara Weibel, Teldja Neige Azzouz Morin, Marlyse C. Knuchel, Armando Zuniga, Marian Wiegand, Martin A. Billeter, Hussein Y. Naim
Publikováno v:
Human Vaccines & Immunotherapeutics
The measles virus vaccine (MVbv) is a clinically certified and well-tolerated vaccine strain that has been given both parenterally and mucosally. It has been extensively used in children and has proven to be safe and effective in eliciting protective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c667e7a5ae1290dab3bd4ee3624072f4
Autor:
Henning Lauterbach, Matthias Mann, Marian Wiegand, Jürgen Cox, Matthias Selbach, Ben Fancke, Jürg Tschopp, Hubertus Hochrein, Christian A. Luber, Shizuo Akira, Meredith O'Keeffe
Publikováno v:
Immunity. 32:279-289
Dendritic cell (DC) populations consist of multiple subsets that are essential orchestrators of the immune system. Technological limitations have so far prevented systems-wide accurate proteome comparison of rare cell populations in vivo. Here, we us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c82229992f771a2d1f8a1833e88e19
https://doi.org/10.1016/j.immuni.2010.01.013
https://doi.org/10.1016/j.immuni.2010.01.013
Autor:
René R. Marty, Hussein Y. Naim, Orhan Ilter, Marian Wiegand, Behazine Combardiere, Marlyse C. Knuchel, Matthias Liniger, Teldja Neige Azzouz Morin, Armando Zuniga
Publikováno v:
Vaccine
Recombinant measles viruses (rMV) based on the live attenuated measles vaccine strain (MVb) expressing antigens of HIV-1 clade B were generated by reverse genetics. Recombinants expressing single or double antigens of HIV-1 (rMV-HIV) were genetically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99e2d9d91fefda557140a65f69f7f86
https://doi.org/10.1016/j.vaccine.2009.01.057
https://doi.org/10.1016/j.vaccine.2009.01.057
Autor:
Azaibi Tamin, René R. Marty, Armando Zuniga, Marian Wiegand, Hussein Y. Naim, Matthias Liniger, Sara Weibel, David J. Kelvin, Marlyse C. Knuchel, Paul A. Rota, Teldja N. Azzouz-Morin
Publikováno v:
Vaccine
Summary Live attenuated recombinant measles viruses (rMV) expressing a codon-optimised spike glycoprotein (S) or nucleocapsid protein (N) of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) were generated (rMV-S and rMV-N). Both re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d440334381040a1f06068414d789472
https://doi.org/10.1016/j.vaccine.2008.01.057
https://doi.org/10.1016/j.vaccine.2008.01.057
Publikováno v:
Journal of Virology. 81:13835-13844
For a long time, Sendai virus (SeV) was used as a model paramyxovirus to study the virus life cycle. Upon infection of a host cell, different stages are completed during replication of the negatively oriented single-stranded RNA genome with its six g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d86944dbe5518f4411be77024ce266c7
https://doi.org/10.1128/jvi.00914-07
https://doi.org/10.1128/jvi.00914-07
Publikováno v:
Journal of General Virology. 86:2305-2314
Induction of apoptosis during Sendai virus (SeV) infection has previously been documented to be triggered by initiator caspases (for strain F) or by a contribution of the cellular protein TIAR (T-cell-activated intracellular antigen-related) (for str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8a55f7f0980ca3262d993310847462
https://doi.org/10.1099/vir.0.81022-0
https://doi.org/10.1099/vir.0.81022-0
Autor:
Marian Wiegand, Barbara Martorelli, Sascha Bossow, Maria Grazia Cusi, Gianni Gori-Savellini, Wolfgang J. Neubert
Publikováno v:
Vaccine. 31(37)
We developed a novel vaccine platform based on a paramyxoviral, genome replication-deficient Sendai virus vector that can express heterologous genes inserted into the genome. To validate the novel approach in vivo , we generated a combined vaccine ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af1b4e9ec94775e6c261b2b4fc63be8
https://pubmed.ncbi.nlm.nih.gov/23831325
https://pubmed.ncbi.nlm.nih.gov/23831325
Autor:
Marian Wiegand, Wolfgang J. Neubert
Publikováno v:
Sendai Virus Vector ISBN: 9784431545552
Vaccines have proven to be the most effective measure against infectious diseases. However, not every infectious disease can be prevented by vaccination at the present time. For some diseases, new vaccination strategies have to be developed because c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5740af8f02aecfdf9deac137ceffe5e8
https://doi.org/10.1007/978-4-431-54556-9_4
https://doi.org/10.1007/978-4-431-54556-9_4